Navigation Links
Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
Date:12/6/2011

ANAHEIM, Calif., Dec. 6, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ:   QCOR) announced today that executive management will present at the Oppenheimer Healthcare Conference to be held on December 13-14, 2011 in New York.  Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Tuesday, December 13, 2011 at 2:45 p.m. ET. 

A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm.  The replay will be available for 90 days after the event.

About Questcor

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company whose primary product, Acthar, helps patients with serious, difficult-to-treat medical conditions.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of acute exacerbations of multiple sclerosis in adults, the treatment of nephrotic syndrome, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus."  Questcor is also exploring the use of Acthar to treat systemic lupus erythematosus, or SLE, for which Acthar is approved as both a maintenance therapy and to treat exacerbations.  Questcor is also exploring the possibility of developing markets for other on-label indications and the possibility of pursuing FDA approval of additional indications not currently on the Acthar label where there is high unmet medical need.
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
2. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on June 9, 2011
3. Questcor Pharmaceuticals to Be Added to S&P SmallCap 600 Index
4. Questcor Announces Third Quarter 2010 Earnings Release Date and Conference Call
5. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
6. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
7. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
8. Access Pharmaceuticals Signs Agreement for CobaCyte® and CobOral® in RNAi Therapeutic Delivery
9. Radient Pharmaceuticals Announces Proxy Resolutions Approved at Special Meeting of Stockholders
10. Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results
11. Optimer Pharmaceuticals Reports Third Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... ATCC, the premier global biological materials ... important appointments to the senior leadership team. Barbie Bigelow ... and Technology and Dr. Maryellen de Mars also joins ... Both roles are new positions at ATCC. ... at ATCC described the additions as part of a ...
(Date:9/23/2014)... 2014  Age Defying Dermatology ® , owned and ... one of the first clinics in the Bay Area ... for tattoo removal. The treatment safely and effectively erases ... tattoo removal has been a lengthy, painful, and all ... an opportunity to erase tattoo pigment more efficiently with ...
(Date:9/23/2014)... , Sept. 23, 2014   GenoSpace , ... comprehensive suite of tools to enable the broad use ... announced that it has been awarded Phase I of ... from the National Institutes of Health (NIH) to enable ... Logo - http://photos.prnewswire.com/prnh/20140922/147649 ...
(Date:9/23/2014)... 2014 Healthcare professionals, patients ... convene at the Society for Integrative Oncology ... October 26-28 in Houston, Texas to discuss ... in individualized integrative cancer care. This multi-disciplinary ... nutritionists, naturopaths, acupuncturists, and other complementary care ...
Breaking Biology Technology:ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3
... Solution Supports Integration of Cardium Health, AirLogix, and Work/Life ... ... Company, BEDFORD, Mass., March 4 ... today,that Nurtur, a subsidiary of Centene Corporation (NYSE: CNC ), ...
... Progress at Seneca, Illinois ... Biodiesel Refinery, ... announced today that it has satisfied the conditions precedent,and completed its ... facility with WestLB AG, one of the world,s leading,financial services providers ...
... 2008 Lets eHarmony Forget About Storage and Focus on ... leading clustered NAS,systems provider, announces the launch of ExaStore ... needs in a full range of,applications and environments., ... storage,requirements, creating a considerable burden," says Dr. Arnon Gat, ...
Cached Biology Technology:Nurtur(TM) Selects CaseNET to Enable Integrated Health and Life Management Capabilities 2Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility 2Exanet Announces ExaStore 2008 Clustered NAS System 2
(Date:9/23/2014)... measure the effects of temperature on insects to predict ... but a Dartmouth study shows for the first time ... temperature, ultimately limits how fast they grow. , "In ... the overall environmental conditions that shape the growth, survival ... Lauren Culler , an Arctic postdoctoral researcher at ...
(Date:9/23/2014)... are fighting a cyberwar against cancer finds that the ... , "Recent research has found that cancer is already ... we studied the interplay between cancer and the immune ... on cancer," said Rice University,s Eshel Ben-Jacob, co-author of ... of the Proceedings of the National Academy of ...
(Date:9/23/2014)... Ill. Scientists have scoured cow rumens and termite ... cell walls for the production of next-generation biofuels, but ... in the human lower intestine, researchers report. , Their ... the National Academy of Sciences , is the first ... microbes in the human gut can digest fiber, breaking ...
Breaking Biology News(10 mins):Insects' fear limits boost from climate change, Dartmouth study shows 2Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3
... N.C. -- Under a landmark agreement signed this week, ... an independent foundation at the Nicholas School of the ... new home, Duke Environment Hall. Research collaborations, ... legendary scientist E.O. Wilson are among the initiatives that ...
... turn parts of our genome off and on at strategic ... cells act and are impacted by environmental factors including diet, ... that aging also effects the epigenome in human skeletal muscle. ... provides a method to study sarcopenia, the degenerative loss ...
... of arsenic exposure regardless of arsenic concentrations in drinking and ... also confirms that toenail clippings are a good biomarker of ... dark meat fish. Exposure to arsenic has been linked to ... low birth weight. The findings appear in ...
Cached Biology News:E.O. Wilson Biodiversity Foundation moving to Duke 2Aging impacts epigenome in human skeletal muscle 2Dartmouth-led study shows diet alone can be significant source of arsenic 2